Roche study reports that Avastin plus Xeloda helped elderly people with metastatic colorectal cancer live four months longer without their disease worsening
Media Releases
30/01/2013
19/11/2012
19/11/2012
Roche study showed that Avastin helped people with newly diagnosed glioblastoma live longer without their disease worsening when added to radiation and chemotherapy
08/11/2012
Health Canada approved the first DNA CMV test to be standardized to the WHO International Standard for CMV quantitation. This first CMV test provides clinical value to help clinicians manage solid organ transplant patients on antiviral therapy.
14/08/2012
HEALTH CANADA APPROVES ANTI-CANCER AGENT TARCEVA AS FIRST-LINE THERAPY IN GENETICALLY DISTINCT TYPE OF NON-SMALL CELL LUNG CANCER
28/06/2012
Roche introduces cobas p 312 pre-analytical system as compact, front-end automation solution for sample management in US and Canada
17/02/2012
FIRST AND ONLY PERSONALIZED TREATMENT FOR DEADLIEST FORM OF SKIN CANCER APPROVED BY HEALTH CANADA
01/02/2012
New Hope Ahead for Children Suffering with Rare Childhood Disease
27/01/2012
Roche enters strategic alliance with Technoclone to expand reagent portfolio for coagulation diagnostics line targeted for US and Canada in 2014.
25/01/2012
|
Approval of first-ever medicine for rare blood vessels diseases offers hope for Canadians |
08/12/2011
Roche announces positive results of pivotal Phase III study with pertuzumab in HER2-positive metastatic breast cancer
05/12/2011
Roche acquires Verum Diagnostica GmbH as part of plan to develop comprehensive coagulation testing portfolio for diagnostic laboratories
29/11/2011
Health Canada approves the cobas® 4800 BRAF V600 Mutation Test, the first Roche companion diagnostic developed with a drug
04/10/2011
Roche to expand coagulation testing portfolio, develop new systems for diagnostic laboratories in US and Canada by 2014
25/08/2011
Roche Canada Supports University of British Columbia
16/08/2011
Roche makes significant investment to establish a global site for Pharmaceutical Development in Canada
12/05/2011
Roche Diagnostics launches its new blood gas analyzer
12/05/2011
Roche Diagnostics launches the cobas® 8000 modular analyzer series in Canada at BC Biomedical Laboratories.
09/03/2011
Roche Diagnostics Canada launches Accu-Chek®Mobile, the world’s first strip-free blood glucose monitoring device
07/03/2011
Pivotal Study Validates Roche’s cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer
07/03/2011
New automated regional lab means better efficiency and increased patient safety
07/10/2010
Roche Diagnostics launches new assays for early detection of Preeclampsia, a serious pregnancy complication. A first in Canada!
09/08/2010
Health Canada approves HERCEPTIN® for patients with HER2-positive advanced stomach cancer
08/07/2010
A New Study Shows that Testing for Human Papillomavirus Genotypes 16 and 18 Detects Cervical Pre-Cancer Missed by Pap Test
14/06/2010
Roche Diagnostics launches post-analytical workflow solution for high volume labs
06/05/2010
Roche Introduces New Health Canada Approved Automated Clinical Laboratory System for Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae
30/04/2010
The CHUS biochemistry and hematology laboratories acquire state of the art technology (in order to provide) enabling faster, safer services
23/10/2009
Health Canada Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
17/10/2009
ACTEMRA inhibits progression of joint destruction in RA patients by over 80% compared to methotrexate alone
13/10/2009
Landmark Genotyping Study Demonstrates the Power of 454 Sequencing Systems for Immunogenetics
05/10/2009
“Rex by Your Side”
13/07/2009
Roche Diagnostics Distributes TheraScreen®: K-RAS Mutation Kit
Test aids physicians to identify colorectal cancer patients who are unlikely to benefit from certain cancer drugs based on their genetic mutations
02/06/2009
Northern Health launches new analyzers and laboratory solution
01/12/2008
Launch of large study on vascular events in noncardiac surgery patients - prospective study to find previously undetected myocardial infarctions through troponin testing
10/09/2008
Battlefords Union Hospital goes live with the Cobas 6000 Chemistry Analyzer
13/05/2008
The Mont Blanc Ascent and organ donation from living donors - Two challenges to out do oneself
28/04/2008
Even easier to use
The new Accu-Chek Compact Plus with all-in-one convenience
28/03/2008
AHSC’s Medical Laboratory at the Saint John Regional Hospital becomes first fully operational, automated and integrated laboratory in the Maritimes
- © 2013 Hoffmann-La Roche Ltd.
- This Web site contains information on products which is targeted to a wide range of audiences in Canada and could contain product details or information otherwise not accessible or valid in another country.
Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage outside Canada.